| Institution | PI Name | Title |
|---|
| Active Pass Pharmaceuticals, Inc. | Ian MacDonald | Development of Alphavirus Replicon Vaccine Against SARS |
| Affymetrix, Inc. | Carsten Roseno | Pathogen and Genetic Element Detection Using Microarrays |
| Alphavax Human Vaccines, Inc. | Jonathan Smith | Development of Alphavirus Replicon Vaccine Against SARS |
| BD Diagnostics | Tobin Hellyer | BD ProbeTec ET for Diagnosis of Influenza and SARS |
| Biota Scientific Management | Jane Ryan | Novel Influenza Biodefense Therapeutic and Prophylactic |
| Chiron Corporation | John Polo | Development of a SARS Coronavirus Vaccine |
| Columbia University Health Sciences | W. Ian Lipkin | Mass Tag PCR Detection of Respiratory Pathogens |
| Delsite Biotechnologies | Yawei Ni | An Inactivated Influenza Nasal Powder Vaccine |
| Dor Biopharma, Inc. | Robert Brey | Development of a Recombinant Vaccine for Ricin Toxin |
| Dynport Vaccine Company, LLC | Ian Henderson | Vitrification-stabilized Multivalent Botulinum Vaccines |
| Dynport Vaccine Company, LLC | Donald Fine | Phase 2 Trial for Venezuelan Equine Encephalitis V3526 |
| Elusys Therapeutics | Linda Nardone | Monoclonal Antibody for Treatment of Inhalation Anthrax |
| Hawaii Biotech, Inc. | Carolyn Weeks-Levy | Clinical Development of a Dengue Vaccine |
| ID Biomedical Corporation of Northborough | Jonathon Seals | Novel cell-culture derived split influenza vaccine |
| ID Biomedical Corporation of Washington | David Burt | Development of Proteosome-adjuvanted nasal SARS vaccines |
| ID Biomedical Corporation of Washington | George Lowell | Development of ProtollinTM Plague Vaccine |
|
| K.U. Leuven Universiteitshal | Johan Neyts | Novel inhibitors of the replication of poxviruses |
| Medarex, Inc. | Israel Lowy | Fully Human Anti-Anthrax Toxin MAbs: Product Development |
| North Shore - Long Island Jewish Research Institute | Howard Trachtman | Human monoclonal antibody therapy for HUS |
| Sequella, Inc. | Carol Nacy | Advancing a new TB drug through early clinical trials |
| Transtech Pharma, Inc. | David Ward | Development of Protease Inhibitor to Treat Smallpox |
| University of Texas, Austin | Steven Kornguth | Diagnostics for Bacterial/Viral Pathogens Including SARS |
| University of Texas Medical Branch, Galveston | Clarence Peters | Rift Valley Fever Virus MP-12 Vaccine Completion |
| Weill Medical College of Cornell University | Carl Nathan | Dihydrolipoamide Acyltransferase:Target for Chemotherapy |
| Weill Medical College of Cornell University | Francis Barany | Multiplexed Detection of Bioterror Agents |